Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Influenza Other Respir Viruses. 2013 Jul;7(4):491-6. doi: 10.1111/irv.12017. Epub 2012 Sep 18.
The performance of rapid influenza diagnostic tests (RIDTs) that detect influenza viral nucleoprotein (NP) antigen has been reported to be variable. Recent human infections with variant influenza A viruses that are circulating in pigs prompted the investigation of the analytical reactivity of RIDTs with these variant viruses.
To determine analytical reactivity of seven FDA-cleared RIDTs with influenza A variant viruses in comparison with the reactivity with recently circulating seasonal influenza A viruses.
Tenfold serial dilutions of cell culture-grown seasonal and variant influenza A viruses were prepared and tested in duplicate with seven RIDTs.
All RIDTs evaluated in this study detected the seasonal influenza A(H3N2) virus, although detection limits varied among assays. All but one examined RIDT identified the influenza A(H1N1)pdm09 virus. However, only four of seven RIDTs detected all influenza A(H3N2)v, A(H1N2)v, and A(H1N1)v viruses. Reduced sensitivity of RIDTs to variant influenza viruses may be due to amino acid differences between the NP proteins of seasonal viruses and the NP proteins from viruses circulating in pigs.
Clinicians should be aware of the limitations of RIDTs to detect influenza A variant viruses. Specimens from patients with influenza-like illness in whom H3N2v is suspected should be sent to public health laboratories for additional diagnostic testing.
已报道,检测流感病毒核蛋白(NP)抗原的快速流感诊断检测(RIDT)的性能存在差异。最近,人感染了在猪中传播的变异型流感 A 病毒,这促使人们研究 RIDT 对这些变异病毒的分析反应性。
与最近流行的季节性流感 A 病毒相比,确定七种获得 FDA 批准的 RIDT 对甲型流感变异病毒的分析反应性。
用七种 RIDT 分别对细胞培养生长的季节性和变异型甲型流感病毒进行十倍连续稀释,并进行重复检测。
本研究中评估的所有 RIDT 均能检测到季节性甲型流感 A(H3N2)病毒,尽管检测限在不同的检测方法中有所不同。除一种 RIDT 外,所有 RIDT 均能识别出甲型流感 A(H1N1)pdm09 病毒。然而,只有七种 RIDT 中的四种能检测到所有甲型流感 A(H3N2)v、A(H1N2)v 和 A(H1N1)v 病毒。RIDT 对变异型流感病毒的敏感性降低可能是由于季节性病毒的 NP 蛋白和在猪中传播的病毒的 NP 蛋白之间存在氨基酸差异。
临床医生应注意 RIDT 检测甲型流感变异病毒的局限性。怀疑患有 H3N2v 的流感样疾病患者的标本应送往公共卫生实验室进行额外的诊断检测。